CLINICAL_TRIALS
trial_result
· 2015-03-06
Clinical Trial Update: S0010 506U78 in Treating Patients With Recurrent or Refractory Acute Lymphocytic Leukemia [Phase 2]
Summary
This update notes that the Phase 2 trial S0010 506U78 for recurrent or refractory acute lymphoblastic leukemia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: SWOG Cancer Research Network | Conditions: Leukemia | Phase 2 | Status: COMPLETED